→   R&D   →   R&D Capability

    R&D Capability

    The manufacturing plant for the product of ‘Botulinum Toxin’,
    PROTOX Research Institute

    Management and manufacturing the safety product via a bio plant with the advanced production facilities.

    Construction of the bio plant

    The bio plant of PROTOX capable of producing and managing ‘Botulinum Toxin’ preparations with a surface area of ​​about 6,280㎡ within the Pharmaceutical Complex of Hyangnam was designed and built in accordance with global GMP guidelines.